CVA Statement on VA’s Inability to Provide Hepatitis C Treatment to Veterans
Arlington, Va. – Concerned Veterans for America (CVA) released the following statement after today’s House Veterans’ Affairs Committee hearing, which examined why the VA is paying $40,000 per veteran for the drug that released the following statement after today’s House Veterans’ Affairs Committee hearing, which examined why the VA is paying $40,000 per veteran for a drug that treats hepatitis C, despite that drug having been developed by a VA employee as part of its research and development function:
“Today’s CBS story regarding the VA’s inability to provide veterans suffering from Hepatitis C with life-saving treatment, despite that treatment being developed by a VA employee using VA resources, is an indictment of the VA’s ability to ensure accountability and protect its own departmental integrity. It also raises troubling questions about how many other VA employees may have used department resources as a vehicle for personal gain.
“When the VA cannot afford to give veterans drugs that its own employees were a part of creating, there is a problem. That the VA recently begged Congress for more taxpayer funds to cover its poor budgeting for these treatments further highlights the VA’s incompetence.
“We hope the VA will be forthcoming in explaining this inability to care for veterans and lack of accountability for taxpayer funds.”
To schedule a TV interview with a CVA expert, please email booking@guestbooker.com. For media inquiries, contact press@cv4a.org.
###
Concerned Veterans for America is a non-partisan, non-profit, 501(c)(4) organization that advocates for policies that will preserve the freedom and prosperity we and our families so proudly fought and sacrificed to defend.